FTC Chair Ferguson Pardons PBMs, Reversing Antitrust Stance

FTC Chair Andrew Ferguson has reportedly halted or reversed enforcement actions against pharmacy benefit managers (PBMs), a reversal of the agency's prior antitrust posture. The move signals a policy shift under the Trump administration, potentially easing regulatory pressure on drug supply chain middlemen. The full scope of the reversal and its impact on drug pricing remains unclear.